³Ô¹ÏÍøÕ¾

Latest anti-cancer News

Novel Selenium Carrier Protein Regulates Ferroptosis in Cancer and Brain
Matcha is having a moment. What are the health benefits of this green tea drink?
Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association
P-bodies Sustain Acute Myeloid Leukemia
Noxopharm announces CRO-67 results in complex pancreatic cancer studies
Ground-breaking study reveals previously unknown genetic causes of colorectal cancer
TeraPore uses Cornell research to address virus filtration challenges
Key To Improving Cancer Treatments Discovered
From immunotherapy to mRNA vaccines – the latest science on melanoma treatment explained
More research supports androgen treatment for breast cancer
La Trobe receives $11.5 million for vital health research
Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack
Tour de Cure backs further development of Noxopharm’s preclinical brain cancer candidate
Targeted liver cancer treatment kills cancer cells and cuts chemo side effects
First step to untangle DNA: supercoiled DNA captures gyrase like a lasso ropes cattle
Study Shows How Oestrogen Protects Against Fatty Liver
Filament formation enables cancer cells’ glutamine addiction
The healing properties of seafood: SCU Buzz
Innovative modelling may help breast cancer patients who don’t respond to treatment
Stromal cells may help predict prostate cancer metastasis
Cracking the code: researchers unravel how mutant protein drives cancer growth
Joint operation seizes $2 million worth of unlawfully imported therapeutic goods
Potential Target for New Anti-Cancer Agents
Cancer’s sweet Achilles heel
Starpharma announces the presentation of DEP irinotecan combination data
Study shows how brain tumors make certain immune cells turn traitor
Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate
New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics
ANSTO scientists would have preferred more about the physics but impressed with Oppenheimer
Potentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitors
The Oligonucleotide Therapeutics Society is Pleased to Announce the 2023 Annual Meeting in Barcelona, Spain
Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response
New CDU studies finds two native Australian plants have healing properties
New CDU study finds two native Australian plants have healing properties
$40k cost saving: New prostate cancer drug listed on PBS
Advanced immunotherapy treatment may hold promise for children with brain cancer
Researchers uncover the first steps driving antibiotic resistance
Discovery key to reducing leukaemia treatment resistance
Exposing tumours to bacteria converts immune cells to cancer killers
Surprise Discovery in Breast Cancer Treatment
Ludwig Princeton study finds cancers are metabolically sluggish and thrifty
Scientists detail major mechanism lung cancers use to evade immune attack
Researchers reveal big Ideas in latest funding win
More than $900,000 provided to support cancer specialists and help improve outcomes for patients
Nano ‘capsule’ to target cancer cells
AstraZeneca showcases strength of haematology portfolio and pipeline across multiple hard-to-treat conditions